LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 1 | L18 | 72 | hr | 868 | 2979 | 3429 | 0.8686 | 0.8628 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 2 | L18 | 72 | hr | 868 | 2884 | 3652 | 0.7897 | 0.7847 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 3 | L18 | 72 | hr | 868 | 2743 | 3587 | 0.7646 | 0.7543 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 1 | L17 | 72 | hr | 868 | 2625 | 3429 | 0.7654 | 0.7476 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 2 | L17 | 72 | hr | 868 | 2749 | 3652 | 0.7527 | 0.7439 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 3 | L17 | 72 | hr | 868 | 2811 | 3587 | 0.7836 | 0.7754 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 1 | L16 | 72 | hr | 868 | 2708 | 3429 | 0.7896 | 0.7753 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 2 | L16 | 72 | hr | 868 | 3127 | 3652 | 0.8562 | 0.8557 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 3 | L16 | 72 | hr | 868 | 3089 | 3587 | 0.8611 | 0.8591 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 1 | L15 | 72 | hr | 868 | 2591 | 3429 | 0.7554 | 0.7361 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 2 | L15 | 72 | hr | 868 | 2811 | 3652 | 0.7697 | 0.7627 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 3 | L15 | 72 | hr | 868 | 2741 | 3587 | 0.7641 | 0.7536 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 1 | L14 | 72 | hr | 868 | 2669 | 3429 | 0.7782 | 0.7623 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 2 | L14 | 72 | hr | 868 | 2885 | 3652 | 0.7900 | 0.7850 |
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 3 | L14 | 72 | hr | 868 | 2963 | 3587 | 0.8260 | 0.8217 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 1 | L13 | 72 | hr | 868 | 2799 | 3429 | 0.8161 | 0.8051 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 2 | L13 | 72 | hr | 868 | 3048 | 3652 | 0.8346 | 0.8330 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 3 | L13 | 72 | hr | 868 | 3144 | 3587 | 0.8764 | 0.8752 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 1 | M18 | 72 | hr | 868 | 3172 | 3429 | 0.9248 | 0.9227 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 2 | M18 | 72 | hr | 868 | 3592 | 3652 | 0.9836 | 0.9841 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 3 | M18 | 72 | hr | 868 | 3250 | 3587 | 0.9060 | 0.9058 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 1 | M17 | 72 | hr | 868 | 3108 | 3429 | 0.9062 | 0.9030 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 2 | M17 | 72 | hr | 868 | 3246 | 3652 | 0.8888 | 0.8895 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 3 | M17 | 72 | hr | 868 | 3054 | 3587 | 0.8513 | 0.8488 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 1 | M16 | 72 | hr | 868 | 2710 | 3429 | 0.7901 | 0.7759 |